OncBioMune, LLC   Report issue

For profit Phase 1 Phase 2
Founded: Baton Rouge LA United States (2005)

Organization Overview

First Clinical Trial
2012
NCT02058680
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

OncBioMune Pharmaceuticals